Massive pancreatic surgery registry launches to improve patient care
NCT ID NCT07443761
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This registry collects information from 2000 people who have had pancreatic surgery for benign or malignant tumors. Researchers track complications and long-term results to understand what works best. The goal is to improve quality of care and support future research.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide valuable insights to improve surgical care and outcomes for people with pancreatic tumors.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects data only and does not test any new therapy, so it cannot directly cure or treat disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PANCREAS TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Antwerp
Edegem, Antwerp, 2650, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?
- Four-Drug cocktail aims to shrink pancreatic tumors before surgery
- Exercise before and after pancreatic cancer surgery may speed recovery and chemotherapy start
- Ultrasound inside the body reveals how tumors block the bile duct
- Could a simple blood test catch pancreatic cancer before It's too late?
- New drug combo aims to boost Chemotherapy's punch against pancreatic cancer